Vagus Nerve Stimulation: Multimedia

References

1. Amar AP, DeGiorgio CM, Tarver WB, Apuzzo ML. Long-term multicenter experience with vagus nerve stimulation for intractable partial seizures: results of the XE5 trial. Stereotact Funct Neurosurg. 1999;73(1-4):104-8. [Medline].

2. Bailey P, Bremer FA. Sensory cortical representation of the vagus nerve. J Neurophysiol. 1938;1:405-12.

3. Ben-Menachem E, Hamberger A, Hedner T, et al. Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res. Mar 1995;20(3):221-7. [Medline].

4. Ben-Menachem E, Hellstrom K, Waldton C, Augustinsson LE. Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years. Neurology. Apr 12 1999;52(6):1265-7. [Medline].

5. Ben-Menachem E, Manon-Espaillat R, Ristanovic R, et al. Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Epilepsia. May-Jun 1994;35(3):616-26. [Medline].

6. Benbadis SR, Tatum WO, Vale FL. When drugs don't work: an algorithmic approach to medically intractable epilepsy. Neurology. Dec 26 2000;55(12):1780-4. [Medline].

7. Benbadis SR, Nyhenhuis J, Tatum WO, et al. MRI of the brain is safe in patients implanted with the vagus nerve stimulator. Seizure. Oct 2001;10(7):512-5. [Medline].

8. Benbadis SR, Tatum WO. Advances in the treatment of epilepsy. Am Fam Physician. Jul 1 2001;64(1):91-8. [Medline].

9. [Best Evidence] DeGiorgio C, Heck C, Bunch S, et al. Vagus nerve stimulation for epilepsy: randomized comparison of three stimulationparadigms. Neurology. Jul 26 2005;65(2):317-9. [Medline].

10. DeGiorgio CM, Schachter SC, Handforth A, et al. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia. Sep 2000;41(9):1195-200. [Medline].

11. Dell P, Olson R. [Thalamic, cortical and cerebellar projections of vagal visceral afferences.]. C R Seances Soc Biol Fil. Jul 1951;145(13-14):1084-8. [Medline].

12. Diaz-Obregon Santos MC, Burzaco JA, Lopez-Lazaro L, et al. Vagus nerve stimulation for the treatment of epilepsy: follow-up of Spanish trial. Epilepsia. 1995;36(Suppl 3):S227.

13. Ferencz I, Strmbland L, Nilson B. Long-term efficacy of vagus nerve stimulation for the treatment of therapy-refractory partial seizures. Epilepsia. 1995;36(Suppl 3):S226.

14. Ferris EB, Capps RB, Weiss S. Carotid sinus syncope and its bearing on the mechanism of unconscious state and convulsions. Medicine. 1934;14:377-453.

15. George R, Salinsky M, Kuzniecky R, et al. Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group. Epilepsia. May-Jun 1994;35(3):637-43. [Medline].

16. Hammond EJ, Uthman BM, Reid SA, et al. Vagus nerve stimulation in humans: neurophysiological studies and electrophysiological monitoring. Epilepsia. 1990;31 Suppl 2:S51-9. [Medline].

17. Handforth A, DeGiorgio CM, Schachter SC, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology. Jul 1998;51(1):48-55. [Medline].

18. Henry TR, Bakay RA, Votaw JR, et al. Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation. Epilepsia. Sep 1998;39(9):983-90. [Medline].

19. Henry TR, Votaw JR, Pennell PB, et al. Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology. Apr 12 1999;52(6):1166-73. [Medline].

20. Hosain S, Nikalov B, Harden C, et al. Vagus nerve stimulation treatment for Lennox-Gastaut syndrome. J Child Neurol. Aug 2000;15(8):509-12. [Medline].

21. Krahl SE, Clark KB, Smith DC, Browning RA. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia. Jul 1998;39(7):709-14. [Medline].

22. Lesser RP. Unexpected places: how did vagus nerve stimulation become a treatment for epilepsy?. Neurology. Apr 12 1999;52(6):1117-8. [Medline].

23. Lundren J, Blenow G, Strombland LG. Vagus nerve stimulation in six children. Epilepsia. 1995;36(Suppl 3):S227.

24. Marrosu F, Maleci A, Cocco E, et al. Vagal nerve stimulation effects on cerebellar tremor in multiple sclerosis. Neurology. Aug 9 2005;65(3):490. [Medline].

25. McLachlan RS. Suppression of interictal spikes and seizures by stimulation of the vagus nerve. Epilepsia. Sep-Oct 1993;34(5):918-23. [Medline].

26. Morris GL, Mueller WM. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology. Nov 10 1999;53(8):1731-5. [Medline].

27. Murphy JV, Hornig G, Schallert G, et al. Left vagal nerve stimulation in children with refractory epilepsy. Preliminary observations. Arch Neurol. Sep 1995;52(9):886-9. [Medline].

28. Penry JK, Dean JC. Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results. Epilepsia. 1990;31 Suppl 2:S40-3. [Medline].

29. Ramsay RE, Uthman BM, Augustinsson LE, et al. Vagus nerve stimulation for treatment of partial seizures: 2. Safety, side effects, and tolerability. First International Vagus Nerve Stimulation Study Group. Epilepsia. May-Jun 1994;35(3):627-36. [Medline].

30. Reid SA. Surgical technique for implantation of the neurocybernetic prosthesis. Epilepsia. 1990;31 Suppl 2:S38-9. [Medline].

31. Rush AJ, George MS, Sackeim HA, et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry. Feb 15 2000;47(4):276-86. [Medline].

32. Rutecki P. Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation. Epilepsia. 1990;31 Suppl 2:S1-6. [Medline].

33. Saneto RP, Sotero de Menezes MA, Ojemann JG, et al. Vagus nerve stimulation for intractable seizures in children. Pediatr Neurol. Nov 2006;35(5):323-6. [Medline].

34. Schachter SC, Saper CB. Vagus nerve stimulation. Epilepsia. Jul 1998;39(7):677-86. [Medline].

35. Tatum WO, Johnson KD, Goff S, et al. Vagus nerve stimulation and drug reduction. Neurology. Feb 27 2001;56(4):561-3. [Medline].

36. Uthman BM, Reichl AM, Dean JC, et al. Effectiveness of vagus nerve stimulation in epilepsy patients: a 12-year observation. Neurology. Sep 28 2004;63(6):1124-6. [Medline].

37. Zabara J. Peripheral control of hypersynchronous discharge in epilepsy. Electroencephalography. 1985;61:S162.

38. Zabara J. Time course of seizure control to brief repetitive stimuli. Epilepsia. 1985;26:518.

39. Zabara J. Controlling seizures by changing GABA receptor sensitivity. Epilepsia. 1987;28:604.

Further Reading

Keywords

VNS, epilepsy, vagal nerve stimulation, vagus nerve stimulation, seizures, refractory epilepsy, seizure control, vagal nerve stimulator, vagal stimulating device, partial-onset seizures, vagus nerve stimulation treatment

Contributor Information and Disclosures

Author

Diego Rielo, MD, Staff Physician, Department of Neurology, Memorial Hospital West, Memorial Hospital Pembroke, Memorial Healthcare
Diego Rielo, MD is a member of the following medical societies: American Academy of Neurology
Disclosure: Nothing to disclose.

Coauthor(s)

Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital
Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Anthony M Murro, MD, Laboratory Director, Professor, Department of Neurology, Medical College of Georgia
Anthony M Murro, MD is a member of the following medical societies: American Academy of Neurology and American Epilepsy Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Jose E Cavazos, MD, PhD, Assistant Professor, Departments of Medicine (Neurology), Pharmacology, and Physiology, University of Texas Health Science Center at San Antonio
Jose E Cavazos, MD, PhD is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, American Epilepsy Society, and Society for Neuroscience
Disclosure: Glaxo-SmithKline Honoraria Speaking and teaching; Ortho-McNeil Neurologics Honoraria Speaking and teaching; UCB Pharma Honoraria Speaking and teaching

CME Editor

Matthew J Baker, MD, Consulting Staff, Collier Neurologic Specialists, Naples Community Hospital
Matthew J Baker, MD is a member of the following medical societies: American Academy of Neurology
Disclosure: Nothing to disclose.

Chief Editor

Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants
Nicholas Y Lorenzo, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Neurology
Disclosure: Nothing to disclose.